NDC 60505-0564

Brimonidine Tartrate 1.5 mg per 1 mL solution/ drops

On the label: Apotex Corp..

Where it's made

This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Apotex Corp. names for other drugs.

Recalls

Mar 1, 2023 · Class II · Apotex Corp.
Lack of sterility assurance: Cracks have developed in some of the units caps of Brimonidine tartrate ophthalmic solution bottles. There is a possibility the broken cap may impact sterility.
Lots: Lots: a) TJ9848 Exp. 02/2024, TJ9849 Exp. 02/2024, TK0258 Exp. 04/2024, TK5341 Exp. 04/2024; b) TK0261 Exp. 04/2024; c) TK0262 Exp. 04/2024

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug: Brimonidine: every company that makes it
Form: solution/ drops, ophthalmic
Strength: 1.5 mg per 1 mL
Approval: ANDA ANDA078479
On the market since: Jan 31, 2022
Package NDCs: 60505-0564-1 60505-0564-2 60505-0564-3
Official label: DailyMed (National Library of Medicine), updated Sep 28, 2026

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?